Nordic Nanovector Publishes Data from the PARADIGME Phase 2 Clinical Trials with Betalutin® on European Clinical Trials Database ...Middle East

OSLO, Norway, April 18, 2023 /PRNewswire/ -- Nordic Nanovector ASA (OSE: NANOV) ("Nordic Nanovector" or the "Company") announces that full results from its Phase 2 clinical trials of Betalutin® (177 Lu lilotomab satetraxetan) in resistant/refractory (R/R) indolent non-Hodgkin's lymphoma...

Hence then, the article about nordic nanovector publishes data from the paradigme phase 2 clinical trials with betalutin on european clinical trials database was published today ( Tuesday 18/04/2023 - 12:36 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Nordic Nanovector Publishes Data from the PARADIGME Phase 2 Clinical Trials with Betalutin® on European Clinical Trials Database )

Also on site :

• Blue Jays Select Austin Voth, Joe Mantiply
• Gabrielle Union Suffers Devastating Family Loss
• TechCrunch Mobility: ‘A stunning lack of transparency’